Crossmark

Antibody responses to influenza vaccine in patients on biological therapy: Results of RIER cohort study

Crossref DOI link: https://doi.org/10.1016/j.medcle.2019.02.031

Published Print: 2019-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Richi, Patricia http://orcid.org/0000-0003-2277-6814
Martín, María Dolores

Navío, María Teresa

González-Hombrado, Laura

Salido, Marina

Llorente, Jesús

Thuissard-Vasallo, Israel

Alcocer, Patricia

Saa-Requejo, Carmen María

Jiménez-Diaz, Ana

Cebrián, Laura

Lojo, Leticia

García-Castro, Marta

Sanz-Rosa, David

Castro, Patricia

Fernández-Rodríguez, Sandra

Martínez de Aramayona, María José

Steiner, Martina

Cobo, Tatiana

García-Fernández, Cristina

Fernández-Castro, Mónica

Illera, Óscar

Valverde, Ricardo

Muñoz-Fernández, Santiago
Funding

Funding for this research was provided by:

Sociedad de Reumatología Comunidad de Madrid (SORCOM)/MSD

Pfizer
License Information

Text and Data Mining valid from 2019-11-01
More Information

This article is maintained by: Elsevier

Article Title: Antibody responses to influenza vaccine in patients on biological therapy: Results of RIER cohort study

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2019.02.031

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2019.02.003

Content Type: article

Copyright: © 2019 Elsevier España, S.L.U. All rights reserved.